CLINICAL EFFICACY OF KUSHMANDA TAILA UTTAR BASTI IN THE MANAGEMENT OF MUTRAGHATA W.S.R. TO BENIGN PROSTATIC HYPERPLASIA (BPH)

Background: Benign Prostatic Hyperplasia (BPH) is a progressive condition characterized by lower urinary tract symptoms (LUTS). In Ayurveda, it is identified as Vatashthila, a subtype of Mutraghata. Current pharmacological interventions often produce side effects such as retrograde ejaculation and hypotension. Objective: To evaluate the clinical efficacy of Kushmanda Taila administered via the Uttar Basti route in reducing prostate volume and improving urinary flow. Methods: Clinical observation of patients receiving 24 ml of sterile Kushmanda Taila intra-urethrally in specific cycles. Parameters included IPSS, PVRU, and Qmax. Results: The data indicated significant improvement in voiding symptoms and a measurable reduction in post-void residual urine. Conclusion: Uttar Basti with Kushmanda Taila is a safe, minimally invasive, and effective localized therapy for BPH.